Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Hologic ( (HOLX) ) is now available.
Hologic, Inc. has expanded its Board of Directors by appointing Martin Madaus, effective December 6, 2024. With over 30 years in diagnostics and life sciences, Madaus brings a wealth of experience from his roles at Carlyle Group and as CEO of Ortho Clinical Diagnostics and Millipore Corporation. This strategic addition aligns with Hologic’s commitment to enhancing leadership for future growth in women’s health technology.
See more insights into HOLX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue